NAME 
HESLOP, Helen Elisabeth 
POSITION TITLE 
Assistant Member, Division of Bone Marrow 
Transplantation, Dept, of Hematology-Oncology 
INSTITUTION AND LOCATION 
University of Otago, Dunedin, New Zealand 
Royal Australasian College of Physicians 
Royal Australasian College of Pathologistn 
University of Otago, Dunedin. New Zealand 
DEGREE 
MB ChB 
FRACP 
FRCPA 
MD 
YEAR 
CONFERRED 
1980 
1987 
1987 
1990 
FIELD OF STUDY 
Medicine 
Medicine 
Hemat / Immunol 
Hematology 
RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position, list, in chronological order, previous employment experience and 
honors. Key personnel include the principal investigator and any other individuals who participate in the scientific development or execution^ ^oHhe oroiecf 
harrSn^TtP IS * ' n J vlduals Wl « h doctoral or other professional degrees, but in some projects will include individuals at the masters or 
au eate level provided they contribute in a substantive way to the scientific development or execution of the project. Include present membership on 
^^! d6ra Government P ubllc advisory committee. List, in chronological order, the titles, all authors, and complete references to alf publications duringthe 
past three years and to representative earlier publications pertinent to this application. DO NOT EXCEED TWO PAGES 
1980-82 
1982-84 
1984-85 
1986-89 
1989-91 
1991 to 
present 
1991 to 
present 
House Officer/Senior House Officer, Canterbury Hospital Board, Christchurch, 
New Zealand 
Medical Registrar, Canterbury Hospital Board, Christchurch, New Zealand 
Senior Registrar in Hematology, Canterbury Hospital Board, Christchurch, New 
Zealand 
Research Fellow/Honorary Lecturer, Royal Free Hospital, London, England 
Postdoctoral Research Associate, Department of Biochemistry and Hematology- 
Oncology, St. Jude Children's Research Hospital, Memphis, TN 
Assistant Professor, Department of Pediatrics, University of 
Tennessee, Memphis, College of Medicine, Tennessee 
Assistant Member, Disivison of Bone Marrow Transplantation, 
Department of Hematology-Oncology, St. Jude Children's Research Hospital, 
Memphis, Tennessee 
PUBLICATIONS (From a total of 46) 
Cordingley FT, Bianchi A, Hoff brand AV, Reittie JE, Heslop HE, Vyakarnam A, Turner M, 
Meager A, Brenner MK. Tumour necrosis factor as an autocrine tumour growth factor 
for chronic B cell malignancies. Lancet i:969-971, 1988. 
Heslop HE, Price GM, Prentice HG, Cordingley FT, Webster ADB, Hoff brand AV, Brenner MK. 
In vitro analysis of the interactions of recombinant IL2 with regenerating lymphoid 
and myeloid cells after allogeneic marrow transplantation. J Immunol 140:3461- 
3466, 1988. 
Bianchi ACM, Heslop HE, Drexler HG, Cordingley FT, Turner M, De Mel WCP, Hoffbrand AV, 
Brenner MK. Effects of tumour necrosis factor and a interferon on chronic B cell 
malignancies. Nouv Rev Fr Heamtol 30:317-319, 1988. 
Reittie JE, Gottlieb DJ, Heslop HE, Leger O, Drexler HG, Hazlehurst G, Hoffbrand AV, 
Prentice HG, Brenner MK. Endogenously activated killer cells circulate after 
autologous and allogeneic marrow transplantation but not after chemotherapy. Blood 
73:1351-1358, 1989. 
Heslop HE, Gottlieb DJ, Reittie JE, Bello-Fernandez C, Meager A, Prentice HG, Brenner MK. 
Spontaneous and Interleukin 2 induced secretion of tumour necrosis factor and gamma 
interferon following autologous marrow transplantation or chemotherapy. Br J 
Haematol 72:122-126, 1989. 
Gottlieb DJ, Brenner MK, Heslop HE, Bianchi ACM, Bello-Fernandez C, Mehta AB, Newland AC, 
Galazka AR, Scott ES, Hoffbrand AV, Prentice HG. A phase 1 clinical trial of 
recombinant Interleukin 2 following high dose chemoradiotherapy for haematological 
malignancy: Applicability to the elimination of minimal residual disease. Br J 
PHS 398 (RevOfl^Pef : blU-bib , iva * . {Form Pfae 6) Page 
Number nanR fifiOBlb lBSHt iiiHi«e<; such Ip 
[277] FF 
